| | HR-TB n = 78 | PDR-TB n = 42 | MDR-TB n = 77 | DS-TB n = 203 |
|---|
R(H) | 78 (100%) | 0 | 0 | 0 |
R (RH) | 0 | 0 | 28 (36.4%) | 0 |
R (HES) | 0 | 38 (90.5%) | 0 | 0 |
R (RHES) | 0 | 0 | 20 (26.0%) | 0 |
R (RHE) | 0 | 0 | 15 (19.5%) | 0 |
R (HE) | 0 | 4 (9.5%) | 0 | 0 |
R (RHS) | 0 | 0 | 14 (18.2%) | 0 |
S (RHES) | 0 | 0 | 0 | 131 (64.5%) |
S (R) | 0 | 0 | 0 | 72 (35.5%) |
- R(H): Resistance to Isoniazid; R (RH): resistant to rifampicin and isoniazid; R (HES): resistance to isoniazid, ethambutol and streptomycin; R (RHES): resistance to rifampicin, isoniazid, ethambutol and streptomycin; R (RHE): resistance to rifampicin, isoniazid and ethambutol; R (HE): Resistance to isoniazid and ethambutol; S (RHES): susceptible to rifampicin, isoniazid, ethambutol and streptomycin; S(R): susceptibility to rifampicin by gene xpert
- HR-TB Isoniazid mono-resistant tuberculosis, PDR-TB poly drug-resistant tuberculosis, MDR-TB multi drug-resistant tuberculosis, DS-TB drug-susceptible tuberculosis
